LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Home・Aandelen Lijst・Exact Sciences Corp

Exact Sciences Corp

Gesloten

SectorGezondheidszorg

54 -3.47

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

53.9

Max

54.96

Belangrijke statistieken
By Trading Economics
Inkomsten	100M -1.2M
Verkoop	104M 811M
Winstmarge	-0.146
Werknemers	6,900
EBITDA	161M 65M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+16.39% upside

Dividenden
By Dow Jones
Volgende Winsten	4 nov 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	1.4B 10B
Vorige openingsprijs	57.47
Vorige sluitingsprijs	54

Nieuwssentiment

By Acuity

50%

175 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

45.6 / 54.37 Steun & Weerstand

Exact Sciences Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 nov 2024, 10:24 UTC

Winsten

These Stocks Are Moving the Most Today: Trump Media, Tesla, First Solar, Coinbase, Super Micro, Nvidia, Exact Sciences, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Exact Sciences Corp Prognose

Koersdoel

By TipRanks

16.39% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 65.18 USD 16.39%

Hoogste 85 USD

Laagste 50 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Exact Sciences Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

19 ratings

Buy

Hold

Sell

Gebaseerd op 19 analisten die aandelenratings hebben gegeven aan Exact Sciences Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

45.6 / 54.37Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

175 / 371 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.